tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Mesoblast Limited Reports 2025 Earnings and Strategic Outlook
PremiumCompany AnnouncementsMesoblast Limited Reports 2025 Earnings and Strategic Outlook
22d ago
Mesoblast reports FY25 net loss ($102.1M) vs. ($88.0M) last year
Premium
The Fly
Mesoblast reports FY25 net loss ($102.1M) vs. ($88.0M) last year
22d ago
Mesoblast options imply 11.6% move in share price post-earnings
Premium
The Fly
Mesoblast options imply 11.6% move in share price post-earnings
22d ago
Mesoblast gives update on Revascor accelerated approval, Ryoncil label extension
PremiumThe FlyMesoblast gives update on Revascor accelerated approval, Ryoncil label extension
3M ago
MESO Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
MESO Earnings Report this Week: Is It a Buy, Ahead of Earnings?
4M ago
Mesoblast gets years of orphan-drug exclusive approval from FDA for Ryoncil
Premium
The Fly
Mesoblast gets years of orphan-drug exclusive approval from FDA for Ryoncil
4M ago
Mesoblast added to S&P/ASX 200 index
PremiumThe FlyMesoblast added to S&P/ASX 200 index
7M ago
Mesoblast’s Earnings Call: RYONCIL Approval & Growth
Premium
Company Announcements
Mesoblast’s Earnings Call: RYONCIL Approval & Growth
7M ago
Buy Rating for Mesoblast Driven by Promising Market Position and Strong Financial Backing
Premium
Ratings
Buy Rating for Mesoblast Driven by Promising Market Position and Strong Financial Backing
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100